Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast

NCT03761758 is registered in ClinicalTrials.gov with SightGlass Vision, Inc. as lead sponsor.

NCT NCT03761758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
Lead sponsor
SightGlass Vision, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2018
Completion date
July 19, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia